药用辅料是药品不可或缺的重要组成部分,其质量和安全性直接影响药品的质量。近年来,几次重大药品安全性事件暴露了药用辅料的风险,对药用辅料的监管显得越来越紧迫。长期以来,我国对于药用辅料尚没有形成专门的注册监管办法。因此,需要从源头上控制药用辅料给药品带来的安全性问题。本研究通过对国内及上海市药用辅料的生产、已批准药用辅料的注册、国内辅料的质量标准、药品生产企业对辅料的使用,以及监管中存在问题的调研与分析,借鉴国际上相关的先进监管办法,提出加强药用辅料监管的建议和对策。
<<Pharmaceutical excipients are essential ingredients for drug products. The quality and safety of excipients directly impact the safety and efficacy of drug products. Some drug safety events in recent years have revealed the safety risks induced by pharmaceutical excipients. It becomes more and more urgent to reinforce the administration of pharmaceutical excipients. However,there’s no specific regulation on administration of pharmaceutical excipients yet. In spite of the strengthen of routine supervision,it is worth to discuss in depth how to combine the risk management philosophy during the approval process,therefore to control the safety risks brought by pharmaceutical excipients at the source. Through the comparisive study on the administration of pharmaceutical excipients between home and abroad,as well as the investigation on the status quo of manufacture and application of excipients at local and other provinces,this research aims to analyse the practical problems existed currently and figure out countermeasures to improve the local administration of excipients,hence to better control the safety risk from excipient and facilitate the development of pharmaceutical industry. This research also gives recommendations on risk management and new registration approaches for pharmaceutical excipient.
<<